Oncosimis Biotech
Oncosimis Biotech Pvt Ltd is dedicated to revolutionizing the biotechnology industry through innovative solutions and scientific excellence. The company focuses on developing biologics and biosimilars using proprietary technologies AcceTT® and BacSec®, aiming to increase yield and reduce production costs. With a team of experienced scientists, doctors, and entrepreneurs, Oncosimis strives to address global challenges such as disease, food security, and environmental sustainability.
Industries
Nr. of Employees
small (1-50)
Oncosimis Biotech
Oncosimis Biotech Pvt Ltd, Plot No 3, Genpact Rd, IDA Uppal, Hyderabad, Telangana, India
Patents
Products
Recombinant endonuclease for nucleic acid removal
Secreted recombinant endonuclease produced in microbial fermentation intended to hydrolyze DNA and RNA into small fragments to reduce viscosity and nucleic acid contamination in bioprocesses.
Recombinant DNase I (RNAse‑free) for mRNA workflows
Recombinant DNase I produced in microbial systems with minimal RNase activity, intended for complete DNA digestion in mRNA production and RNA analysis workflows.
Recombinant endonuclease for nucleic acid removal
Secreted recombinant endonuclease produced in microbial fermentation intended to hydrolyze DNA and RNA into small fragments to reduce viscosity and nucleic acid contamination in bioprocesses.
Recombinant DNase I (RNAse‑free) for mRNA workflows
Recombinant DNase I produced in microbial systems with minimal RNase activity, intended for complete DNA digestion in mRNA production and RNA analysis workflows.
Services
Collaborative development to optimize expression, fermentation/cell culture and purification processes to increase yield and enable scale-up for therapeutic proteins and antibodies.
Provision of recombinant endonucleases and RNAse-free DNase I preparations for reduction of nucleic acid contamination and cell lysate viscosity in research and industrial production.
Collaborative development to optimize expression, fermentation/cell culture and purification processes to increase yield and enable scale-up for therapeutic proteins and antibodies.
Provision of recombinant endonucleases and RNAse-free DNase I preparations for reduction of nucleic acid contamination and cell lysate viscosity in research and industrial production.
Expertise Areas
- Biologics and biosimilars development
- Recombinant protein and enzyme production
- Microbial fermentation process development
- Mammalian cell (CHO) upstream process development
Key Technologies
- Microbial fermentation (E. coli)
- Mammalian cell culture (CHO)
- Recombinant protein expression
- Protein purification and chromatography
News & Updates
Oncosimis Biotech received the Hy10 award from HYSEA.
Oncosimis Biotech was selected for the BioAsia 2020 Best Start-up award.
Hyderabad is recognized as an incubator for firms engaged in the war on cancer, including Oncosimis.
Oncosimis Biotech received the Hy10 award from HYSEA.
Oncosimis Biotech was selected for the BioAsia 2020 Best Start-up award.
Hyderabad is recognized as an incubator for firms engaged in the war on cancer, including Oncosimis.